Rab Faruqi

804 total citations
20 papers, 607 citations indexed

About

Rab Faruqi is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Rab Faruqi has authored 20 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 12 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology and Allergy. Recurrent topics in Rab Faruqi's work include Asthma and respiratory diseases (14 papers), Respiratory and Cough-Related Research (11 papers) and Hepatitis C virus research (5 papers). Rab Faruqi is often cited by papers focused on Asthma and respiratory diseases (14 papers), Respiratory and Cough-Related Research (11 papers) and Hepatitis C virus research (5 papers). Rab Faruqi collaborates with scholars based in United States, South Korea and Thailand. Rab Faruqi's co-authors include Gary S. Rachelefsky, Yuning Liao, Sundeep Salvi, Philip J. Thompson, De Yun Wang, Shiva Sajjan, Sanguansak Thanaviratananich, Aloke Gopal Ghoshal, Abdul Razak Muttalif and Watchara Boonsawat and has published in prestigious journals such as Hepatology, Journal of Allergy and Clinical Immunology and Journal of Hepatology.

In The Last Decade

Rab Faruqi

20 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rab Faruqi United States 14 349 321 128 115 111 20 607
Lamont Sweet Canada 10 125 0.4× 108 0.3× 95 0.7× 28 0.2× 16 0.1× 14 419
David R. Mink United States 14 565 1.6× 548 1.7× 67 0.5× 12 0.1× 90 0.8× 24 804
Suchai Charoenratanakul Thailand 10 199 0.6× 393 1.2× 152 1.2× 4 0.0× 34 0.3× 20 565
Christopher D. Codispoti United States 14 220 0.6× 103 0.3× 25 0.2× 4 0.0× 176 1.6× 29 503
MohamedS Al-Moamary Saudi Arabia 6 154 0.4× 160 0.5× 51 0.4× 4 0.0× 11 0.1× 8 297
S. Bourke United Kingdom 9 74 0.2× 130 0.4× 59 0.5× 3 0.0× 14 0.1× 24 315
Patricia McFeeley United States 11 81 0.2× 67 0.2× 50 0.4× 6 0.1× 42 0.4× 21 486
Stephanie Watkins United States 8 47 0.1× 58 0.2× 260 2.0× 61 0.5× 8 0.1× 16 451
Melanie Gleason United States 13 312 0.9× 204 0.6× 25 0.2× 2 0.0× 147 1.3× 26 602
Bilun Gemicioğlu Türkiye 12 389 1.1× 343 1.1× 25 0.2× 121 1.1× 73 578

Countries citing papers authored by Rab Faruqi

Since Specialization
Citations

This map shows the geographic impact of Rab Faruqi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rab Faruqi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rab Faruqi more than expected).

Fields of papers citing papers by Rab Faruqi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rab Faruqi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rab Faruqi. The network helps show where Rab Faruqi may publish in the future.

Co-authorship network of co-authors of Rab Faruqi

This figure shows the co-authorship network connecting the top 25 collaborators of Rab Faruqi. A scholar is included among the top collaborators of Rab Faruqi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rab Faruqi. Rab Faruqi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, De Yun, Sang‐Heon Cho, Horng-Chyuan Lin, et al.. (2018). Practice Patterns for Chronic Respiratory Diseases in the Asia-Pacific Region: A Cross-Sectional Observational Study. International Archives of Allergy and Immunology. 177(1). 69–79. 4 indexed citations
2.
Wang, De Yun, Aloke Gopal Ghoshal, Abdul Razak Muttalif, et al.. (2016). Quality of Life and Economic Burden of Respiratory Disease in Asia-Pacific—Asia-Pacific Burden of Respiratory Diseases Study. Value in Health Regional Issues. 9. 72–77. 38 indexed citations
3.
Thanaviratananich, Sanguansak, Sang‐Heon Cho, Aloke Gopal Ghoshal, et al.. (2016). Burden of respiratory disease in Thailand. Medicine. 95(28). e4090–e4090. 26 indexed citations
4.
Lin, Horng‐Chyuan, Sang‐Heon Cho, Aloke Gopal Ghoshal, et al.. (2016). Respiratory diseases and the impact of cough in Taiwan. Medicine. 95(27). e3854–e3854. 14 indexed citations
5.
Cho, Sang‐Heon, Horng‐Chyuan Lin, Aloke Gopal Ghoshal, et al.. (2016). Respiratory disease in the Asia-Pacific region: Cough as a key symptom. Allergy and Asthma Proceedings. 37(2). 131–140. 38 indexed citations
6.
Yoo, Kwang Ha, Jong‐Woong Kim, Aloke Gopal Ghoshal, et al.. (2016). Burden of Respiratory Disease in Korea: An Observational Study on Allergic Rhinitis, Asthma, COPD, and Rhinosinusitis. Allergy Asthma and Immunology Research. 8(6). 527–527. 67 indexed citations
7.
8.
Salvi, Sundeep, Komalkirti Apte, Raja Dhar, et al.. (2015). Asthma Insights and Management in India: Lessons Learnt from the Asia Pacific - Asthma Insights and Management (AP-AIM) Study.. PubMed. 63(9). 36–43. 34 indexed citations
9.
Wang, D.Y., Anish Ghoshal, Horng-Chyuan Lin, et al.. (2014). COUGH AS A KEY SYMPTOM IN ASTHMA, ALLERGIC RHINITIS, COPD AND RHINOSINUSITIS AND ITS IMPACT IN ASIA. Value in Health. 17(7). A776–A777. 5 indexed citations
10.
Boonsawat, Watchara, et al.. (2014). Survey of asthma management in Thailand - the asthma insight and management study. Asian Pacific Journal of Allergy and Immunology. 33(1). 14–20. 29 indexed citations
11.
Gold, Laura S., Phillip Thompson, Sundeep Salvi, Rab Faruqi, & Sean D. Sullivan. (2013). Level of asthma control and health care utilization in Asia-Pacific countries. Respiratory Medicine. 108(2). 271–277. 48 indexed citations
12.
Thompson, Philip J., Sundeep Salvi, Jiangtao Lin, et al.. (2013). Insights, attitudes and perceptions about asthma and its treatment: Findings from a multinational survey of patients from 8 Asia‐Pacific countries and Hong Kong. Respirology. 18(6). 957–967. 88 indexed citations
13.
Craxı̀, Antonio, Liliana Chemello, Mojca Matičič, et al.. (2011). Peginterferon alfa‐2b plus weight‐based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve rapid viral response. Journal of Viral Hepatitis. 19(2). e120–5. 5 indexed citations
14.
Manns, Michael P., Stefan Zeuzem, Ajit Sood, et al.. (2011). Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C. Journal of Hepatology. 55(3). 554–563. 42 indexed citations
15.
Buti, Marı́a, Yoav Lurie, Н. П. Блохина, et al.. (2010). Randomized Trial of Peginterferon alfa-2b and Ribavirin for 48 or 72 Weeks in Patients with Hepatitis C Virus Genotype 1 and Slow Virologic Response. Hepatology. 52(4). 1201–1207. 52 indexed citations
16.
Buti, Marı́a, Yoav Lurie, Н. П. Блохина, et al.. (2009). 141 EXTENDED TREATMENT DURATION IN CHRONIC HEPATITIS C GENOTYPE 1-INFECTED SLOW RESPONDERS: FINAL RESULTS OF THE SUCCESS STUDY. Journal of Hepatology. 50. S58–S58. 14 indexed citations
17.
Manns, M.P., Stefan Zeuzem, Ajit Sood, et al.. (2009). 144 REDUCED DOSE AND DURATION OF PEGINTERFERON ALFA-2B + WEIGHT-BASED RIBAVIRIN IN EUROPEAN AND ASIAN GENOTYPE 2 AND 3 CHRONIC HEPATITIS C PATIENTS (REDD 2/3 TRIAL). Journal of Hepatology. 50. S59–S59. 5 indexed citations
18.
Rachelefsky, Gary S., Yuning Liao, & Rab Faruqi. (2007). Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysis. Annals of Allergy Asthma & Immunology. 98(3). 225–238. 69 indexed citations
19.
Rachelefsky, Gary S., et al.. (2006). Inhaled Corticosteroids and the Risk of Oropharyngeal Adverse Events: Results from a Meta-Analysis. Journal of Allergy and Clinical Immunology. 117(2). S92–S92. 3 indexed citations
20.
Weber, Richard W., et al.. (2006). Safety and clinical relief over 1 year with triamcinolone acetonide hydrofluoroalkane-134a nasal aerosol in patients with perennial allergic rhinitis. Allergy and Asthma Proceedings. 27(3). 243–247. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lamont Sweet Breakdown of academic impact, for papers by David R. Mink Breakdown of academic impact, for papers by Suchai Charoenratanakul Breakdown of academic impact, for papers by Christopher D. Codispoti Breakdown of academic impact, for papers by MohamedS Al-Moamary Breakdown of academic impact, for papers by S. Bourke Breakdown of academic impact, for papers by Patricia McFeeley Breakdown of academic impact, for papers by Stephanie Watkins Breakdown of academic impact, for papers by Melanie Gleason Breakdown of academic impact, for papers by Bilun Gemicioğlu
Rankless by CCL
2026